Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.
Hironari HanaokaHarunobu IidaTomofumi KiyokawaYukiko TakakuwaTakahiro OkazakiHidehiro YamadaShoichi OzakiKimito KawahataPublished in: PloS one (2018)
Addition of anti-platelet therapy was associated with an improvement of eGFR in LA-positive patients with LN class III or IV.